MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zocor 10mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zocor 10mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zocor 20mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zocor 20mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zocor 20mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zocor 40mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

Tablet designed to dissolve on tongue - unsuitable for MCA

Provenance

Compatibility recommendation derived from Zofran Melt 4mg oral lyophilisates (Novartis Pharmaceuticals UK Ltd).

Stability Notes

Tablet designed to dissolve on tongue - unsuitable for MCA

Provenance

Compatibility recommendation derived from Zofran Melt 4mg oral lyophilisates (Novartis Pharmaceuticals UK Ltd).

Stability Notes

Tablet designed to dissolve on tongue - unsuitable for MCA

Provenance

Compatibility recommendation derived from Zofran Melt 4mg oral lyophilisates (Novartis Pharmaceuticals UK Ltd).

Stability Notes

Tablet designed to dissolve on tongue - unsuitable for MCA

Provenance

Recommendation derived from Zofran Melt 8mg oral lyophilisates (Novartis Pharmaceuticals UK Ltd).

Stability Notes

Tablet designed to dissolve on tongue - unsuitable for MCA

Provenance

Recommendation derived from Zofran Melt 8mg oral lyophilisates (Novartis Pharmaceuticals UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.